Indicated for: multiple sclerosis
Route of administration: injectable
Substance: interferon beta 1A (interferon)
ATC: L03AB07 (Antineoplastic and immunomodulating agents | Immunostimulants | Interferons)
Interferon beta-1A is a medication used for the treatment of relapsing multiple sclerosis. It works by modulating the immune response, reducing the frequency of relapses and slowing disease progression.
The medication is administered as a subcutaneous or intramuscular injection, as directed by a doctor, usually once or several times a week. It is important for patients to follow the treatment regimen and undergo regular check-ups.
Patients should be aware of potential side effects, such as flu-like symptoms, injection site reactions, or fatigue. It is important to inform the doctor of any unusual symptoms.
Common side effects include flu-like symptoms, injection site reactions, and fatigue. In rare cases, severe reactions such as depression or liver impairment may occur. Patients should be informed of these risks before starting treatment.